First Time Loading...

Taisho Pharmaceutical Holdings Co Ltd
TSE:4581

Watchlist Manager
Taisho Pharmaceutical Holdings Co Ltd Logo
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Watchlist
Price: 8 570 JPY Market Closed
Updated: Mar 29, 2024

Intrinsic Value

Taisho Pharmaceutical Holdings Co. Ltd. engages in the management of its group companies which are engaged in the manufacture and sale of over-the-counter (OTC) drugs, food, and miscellaneous goods. [ Read More ]

The intrinsic value of one Taisho Pharmaceutical Holdings Co Ltd stock under the Base Case scenario is 5 057.79 JPY. Compared to the current market price of 8 570 JPY, Taisho Pharmaceutical Holdings Co Ltd is Overvalued by 41%.

Key Points:
Intrinsic Value
Base Case
5 057.79 JPY
Overvaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Taisho Pharmaceutical Holdings Co Ltd

Backtest Taisho Pharmaceutical Holdings Co Ltd Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Taisho Pharmaceutical Holdings Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Taisho Pharmaceutical Holdings Co Ltd's business.

What risks and challenges
does Taisho Pharmaceutical Holdings Co Ltd face in the near future?

Summarize the latest earnings report
of Taisho Pharmaceutical Holdings Co Ltd.

Provide P/E
for Taisho Pharmaceutical Holdings Co Ltd and its competitors.

Financials

Balance Sheet Decomposition
Taisho Pharmaceutical Holdings Co Ltd

Current Assets 416.8B
Cash & Short-Term Investments 266.4B
Receivables 72.6B
Other Current Assets 77.9B
Non-Current Assets 588.7B
Long-Term Investments 167.6B
PP&E 149B
Intangibles 247.5B
Other Non-Current Assets 24.5B
Current Liabilities 80.8B
Accounts Payable 16.5B
Accrued Liabilities 21.1B
Other Current Liabilities 43.3B
Non-Current Liabilities 92.5B
Other Non-Current Liabilities 92.5B
Efficiency

Earnings Waterfall
Taisho Pharmaceutical Holdings Co Ltd

Revenue
320.4B JPY
Cost of Revenue
-137.2B JPY
Gross Profit
183.2B JPY
Operating Expenses
-164.3B JPY
Operating Income
18.9B JPY
Other Expenses
-10.5B JPY
Net Income
8.4B JPY

Free Cash Flow Analysis
Taisho Pharmaceutical Holdings Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Taisho Pharmaceutical Holdings Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
49/100
Profitability
Score

Taisho Pharmaceutical Holdings Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Taisho Pharmaceutical Holdings Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Long-Term Solvency
Low D/E
88/100
Solvency
Score

Taisho Pharmaceutical Holdings Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Taisho Pharmaceutical Holdings Co Ltd

Wall Street analysts forecast Taisho Pharmaceutical Holdings Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Taisho Pharmaceutical Holdings Co Ltd is 5 600 JPY .

Lowest
Price Target
Not Available
Average
Price Target
5 600 JPY
35% Downside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Taisho Pharmaceutical Holdings Co Ltd

1M 1M
0%
6M 6M
+39%
1Y 1Y
+57%
3Y 3Y
+18%
5Y 5Y
-13%
10Y 10Y
+16%
Annual Price Range
8 570
52w Low
5 180
52w High
8 753
Price Metrics
Average Annual Return -12.74%
Standard Deviation of Annual Returns 13.44%
Max Drawdown -54%
Shares Statistics
Market Capitalization 702.5B JPY
Shares Outstanding 82 094 593
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Taisho Pharmaceutical Holdings Co Ltd Logo
Taisho Pharmaceutical Holdings Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

702.5B JPY

Dividend Yield

1.17%

Description

Taisho Pharmaceutical Holdings Co. Ltd. engages in the management of its group companies which are engaged in the manufacture and sale of over-the-counter (OTC) drugs, food, and miscellaneous goods. The company is headquartered in Toshima, Tokyo-To and currently employs 9,134 full-time employees. The company went IPO on 2011-10-03. The firm operates in two business segments. The Self-Medication segment is engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of ethical drugs. The other business is engaged in the leasing and management of real estate, as well as hotel management business.

Contact

TOKYO-TO
Toshima
3-24-1, Takada
+81339852020.0
http://www.taisho-holdings.co.jp/

IPO

2011-10-03

Employees

9 134

Officers

CEO & Representative Director
Mr. Akira Uehara
General Manager of Corporate Communications
Shinichi Tanaka
MD & Executive Director
Mr. Ken Uehara
Executive Director
Mr. Tetsu Watanabe
Executive VP & Director
Mr. Jun Kuroda

See Also

Discover More
What is the Intrinsic Value of one Taisho Pharmaceutical Holdings Co Ltd stock?

The intrinsic value of one Taisho Pharmaceutical Holdings Co Ltd stock under the Base Case scenario is 5 057.79 JPY.

Is Taisho Pharmaceutical Holdings Co Ltd stock undervalued or overvalued?

Compared to the current market price of 8 570 JPY, Taisho Pharmaceutical Holdings Co Ltd is Overvalued by 41%.